Luisa Soto

56PUBLICATIONS
490CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Aug 18, 2026
Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.

|Jun 29, 2026
A pilot translational study of neoadjuvant fulvestrant plus abemaciclib in women with advanced low-grade serous carcinoma.

|May 28, 2026
Pan-cancer spatial atlas of tertiary lymphoid structures.

|May 08, 2026
FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate.

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

Pageof 10

Frequent Collaborators

20 joint publications

Edwin Roger Parra Cuentes

15 joint publications

John Victor Heymach

14 joint publications

Cara L Haymaker

14 joint publications

Ruiping Wang